Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital)
Man or woman from 18 years old and without upper age limit
Patient followed in pulmonology at Strasbourg University Hospital
Patient presenting at least one of the following pathologies:
1. severe persistent asthma (200 patients)
2. chest cancer that is active or has received treatment within a period of less than one year (300 patients)
3. history of lung transplantation performed before the start of the epidemic (02/29/2020) (300 patients)
4. idiopathic or other diffuse interstitial lung disease, sarcoidosis or vasculitis (70 patients)
5. pulmonary arterial hypertension (PAH) (group 1 of the international classification) any cause or chronic thromboembolic PAH (group 4): (60 patients)
6. Severe COPD in the respiratory failure stage (150 patients)
Subject affiliated to a social health insurance protection scheme
Subject able to understand the objectives of the research
Subject having signed an informed consent
You may not be if
Inability to provide informed information about the subject (subject in an emergency situation, difficulty in understanding the subject, etc.)
Subject under safeguard of justice
Subject under guardianship or guardianship
Clareo Health | Study of seroPREvalence Vis-à-vis SARS-CoV2 and Correlation With Clinical Forms of COVID-19 in Patients Followed in Pneumology in the Cluster Area of the Grand-Est Region (Strasbourg University Hospital)
